Overview
Hepatocellular carcinoma (HCC) almost always develops in patients with chronic liver disease — especially cirrhosis and chronic hepatitis B. When found small (<3 cm) on surveillance, cure rates are high. When found late, treatment is palliative. Surveillance is the single most important factor in survival.
Symptoms
Surveillance is for ASYMPTOMATIC patients — the goal is to find HCC before symptoms
When symptoms appear, the cancer is usually advanced
Self-Care Tips
Get ultrasound + AFP every 6 months without fail.
Treat underlying liver disease aggressively (antivirals for HBV, weight loss for MASLD, abstinence from alcohol).
Stop alcohol completely.
Vaccinate against hepatitis A and B.
When to See a Doctor
Seek medical care promptly if you notice: Worsening cirrhosis (new ascites, jaundice, weight loss).
Why it happens
Years of liver inflammation lead to genetic damage and eventually cancer. Higher risk: cirrhosis from any cause, chronic hepatitis B (even without cirrhosis), MASH, alcohol, hemochromatosis, Asian/African ancestry, family history of HCC.
How common it is
HCC risk: ~3-5% per year in patients with cirrhosis. Lower in chronic hepatitis B without cirrhosis (~0.5%/year).
How it is diagnosed
Surveillance: liver ultrasound + AFP every 6 months. Suspicious lesion → triple-phase CT or MRI with contrast — these can diagnose HCC without biopsy in many cases. Biopsy if imaging uncertain.
Lifestyle and daily habits
Adherence to surveillance schedule is the critical task.
• Get ultrasound + AFP every 6 months without fail.
• Treat underlying liver disease aggressively (antivirals for HBV, weight loss for MASLD, abstinence from alcohol).
• Stop alcohol completely.
• Vaccinate against hepatitis A and B.
Diet
Mediterranean diet plus underlying disease management.
• Coffee 3-4 cups daily (unsweetened) is protective.
Medicines
No specific drugs for screening — treat underlying liver disease.
• Antivirals for chronic hepatitis B can reduce HCC risk.
Procedures and surgery
Surveillance is the procedure.
• Ultrasound + AFP every 6 months.
• CT or MRI for suspicious lesions on ultrasound.
• Treatment depends on stage at detection.
Outlook
Early HCC found on surveillance: 5-year survival often >70% with surgery, transplant, or ablation. Late HCC: median survival 6-12 months. Surveillance saves lives — adherence is the challenge.
Questions to ask your doctor
• When is my next ultrasound and AFP due?
• Am I in the high-risk group requiring surveillance?
Source and review
This guide comes from the Saudi Gastroenterology Association (SGA) patient library, prepared by the SGA Hepatology Panel. Last reviewed: 2026-04-24. It is for education and does not replace your doctor's advice.
Frequently Asked Questions
What is Liver Cancer Surveillance?
How is Liver Cancer Surveillance diagnosed?
What is the outlook for Liver Cancer Surveillance?
When should I see a doctor about Liver Cancer Surveillance?
Share this with someone who needs it: